The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure

The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure

Background: The current post-procedure antithrombotic recommendation for left atrial appendage closure (LAAC) remains empiric. This study was designed to compare variations in platelet activation biomarkers and device-related thrombosis (DRT) under different antithrombotic regimens following LAAC.Me...

Full description

Bibliographic Details
Main Authors: Xiaoye Li, Xiaochun Zhang, Qinchun Jin, Yanli Li, Daxin Zhou, Qianzhou Lv, Junbo Ge
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pharmacology
Subjects:
direct oral anticoagulants
percutaneous left atrial appendage closure
device-related thrombosis
thrombin receptor–activating peptide–induced platelet aggregation
platelet activation biomarkers
thrombin–antithrombin complex
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.723905/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.723905/full

Similar Items